Amneal Pharmaceuticals, Inc. - News - Press Releases

2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Dec 29, 2010

Impax Laboratories Receives Final FDA Approval for Generic Doryx(R) 75 and 100mg Tablets

Dec 16, 2010

GlaxoSmithKline and Impax Pharmaceuticals Enter Global Agreement to Develop and Commercialize a late stage compound for Parkinson's Disease

Dec 03, 2010

Impax Laboratories Confirms Patent Challenge Relating to INTUNIVTM, 4 mg

Nov 29, 2010

Impax Laboratories Confirms Patent Suit Relating to Generic Concerta(R) 54 mg Tablets

Nov 26, 2010

Impax Laboratories to Present at the Piper Jaffray Annual Healthcare Conference

Nov 26, 2010

Impax Laboratories Confirms Patent Challenge Relating to SIMCOR(R) Extended-Release Tablets, 1000/20 mg

Nov 23, 2010

What Patients Should Know About Generic Drugs: A Resource Guide for Pharmacists

Nov 22, 2010

Impax Confirms Patent Challenge Relating to WELCHOL(R) for Oral Suspension, 3.75 gm/packet and 1.875 gm/packet

Nov 22, 2010

Impax Laboratories Receives Tentative FDA Approval for Generic Cymbalta(R) Delayed-Release 20, 30 and 60 mg Capsules

Nov 18, 2010

Impax Pharmaceuticals Announces IPX066 Demonstrates Efficacy and Safety in APEX-PD Phase III Study in Treatment of Early Parkinson's Disease

Nov 16, 2010

Impax Laboratories Receives Final FDA Approval for Generic Allegra-D 60mg/120mg Tablets

Nov 05, 2010

Impax Laboratories to Present at the Credit Suisse 19th Annual Healthcare Conference

Nov 02, 2010

Impax Laboratories Reports Growth in Revenue, Profit and Earnings in the Third Quarter 2010

Nov 01, 2010

Impax Laboratories Announces Litigation Against Shire Relating to Supply of Generic Adderall XR(R)

Oct 04, 2010

Impax Laboratories Schedules Conference Call and Webcast for Third Quarter 2010 Financial Results

Sep 30, 2010

Impax Laboratories to Present at the Jefferies 2010 Global SpecPharma and European Healthcare Conference

Sep 20, 2010

Amneal Pharmaceuticals to Host Grand Opening of New Glasgow, KY Distribution and Sales Center on

Sep 15, 2010

Impax Laboratories to Present at the UBS Global Life Sciences Conference

Sep 08, 2010

Impax Laboratories to Present at the Morgan Stanley Global Healthcare Conference

Aug 26, 2010

Amneal Announces FDA Approval For Spironolactone HCL Tablets

Aug 25, 2010

Impax Pharmaceuticals Completes Enrollment in ADVANCE-PD Phase III Trial of IPX066 in Parkinson's Disease

Aug 20, 2010

Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mg

Aug 05, 2010

Impax Laboratories Enters Into Development Agreement with Perrigo

Aug 03, 2010

Impax Laboratories Continues Strong Growth in Revenue, Profit and Earnings in the Second Quarter 2010

Jul 27, 2010

Amneal Pharmaceuticals Receives Five Generics Industry Awards For Customer Value and Service Excellence

Jul 22, 2010

Impax Laboratories Receives Final FDA Approval for Generic OPANA(R) ER Tablets

Jul 08, 2010

Amneal Appoints Dr. Shankar Hariharan as Chief Scientific Officer/EVP of Specialty Pharmaceuticals

Jul 08, 2010

Impax Laboratories Schedules Conference Call and Webcast for Second Quarter 2010 Financial Results

Jul 02, 2010

Impax Laboratories Confirms Patent Challenge Relating to RENVELA(R), 2.4 g and 0.8 g (For Suspension)

Jun 18, 2010

Impax Laboratories to Present at the Wells Fargo Securities Healthcare Conference

Jun 15, 2010

Amneal Receives FDA Approval for Lorazepam Oral Concentrate, USP

Jun 08, 2010

Impax Laboratories and Endo Pharmaceuticals Settle Pending Litigation for Opana(R) ER and Announce Development and Co-Promotion Agreement

Jun 07, 2010

Impax Laboratories to Present at Upcoming Investor Conferences on June 10

May 26, 2010

Impax Laboratories Enters Into Development and Supply Agreement with IGI Laboratories

May 25, 2010

Mpax Laboratories Announces Voting Results from 2010 Annual Meeting of Stockholders

May 14, 2010

Impax Laboratories Receives Tentative FDA Approval for Generic Opana(R) ER 5, 7.5, 10, 15, 20, 30 and 40 mg Tablets

May 11, 2010

Impax Laboratories to Present at the Goldman Sachs 31st Annual Global Healthcare Conference

May 10, 2010

Impax Laboratories to Present at the Bank of America Merrill Lynch Health Care Conference

May 08, 2010

Impax Laboratories and Endo Pharmaceuticals Settle Pending Litigation for Opana(R) ER and Announce Development and Co-Promotion Agreement

May 04, 2010

Impax Laboratories Reports Significant Growth for the First Quarter 2010

May 02, 2010

Impax Laboratories to Present at the Deutsche Bank 35th Annual Health Care Conference

Apr 29, 2010

Impax Laboratories Confirms Patent Challenge Relating to Fenoglide(R) 40 and 120 mg Tablets

Apr 19, 2010

Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease

Apr 15, 2010

Impax Pharmaceuticals Announces Amendment of Co-Promotion Agreement

Apr 15, 2010

Impax Pharmaceuticals Completes Enrollment in APEX-PD Phase III Trial of IPX066 in Parkinson's Disease

Apr 08, 2010

Allen Chao, Ph.D. Elected to Impax Laboratories Board of Directors

Apr 06, 2010

Impax Laboratories Schedules Conference Call for First Quarter 2010 Financial Results

Mar 17, 2010

Impax Laboratories to Present at the Barclays Capital 2010 Global Healthcare Conference

Mar 15, 2010

Impax Laboratories Confirms Patent Challenge Relating to TRILIPIX(R) Delayed-Release Capsules, 135 mg and 45 mg

Mar 04, 2010

Impax Laboratories to Present at the Cowen & Co. 30th Annual Health Care Conference on March 9, 2010

Mar 02, 2010

Impax Laboratories Receives Final FDA Approval for Generic FLOMAX(R) 0.4mg Capsules and Immediately Commences Shipment

Feb 26, 2010

Impax Laboratories to Appear at the RBC Capital Markets Healthcare Conference on Tuesday, March 2, 2010

Feb 25, 2010

Impax Laboratories Reports Record Growth in Revenue, Net Income and Earnings for the Fourth Quarter and Full Year 2009

Jan 21, 2010

Impax Laboratories Schedules Conference Call for Fourth Quarter and Full Year 2009 Financial Results

Jan 16, 2010

Impax Laboratories to Present at the 28th Annual J.P. Morgan Healthcare Conference

Jan 15, 2010

Impax Laboratories Confirms Patent Challenge Relating to WELCHOL(R) 625 mg Tablets

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.14.0.5